Last $13.32 USD
Change Today +0.19 / 1.45%
Volume 228.0K
VNDA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Howard H. Pien

Director and Chairman of Compensation Committee, ImmunoGen, Inc.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 6 different organizations across 10 different industries.

See Board Relationships
56$104,000

Background*

Mr. Howard H. Pien serves as an Advisor to the Life Sciences Practice at Warburg Pincus. Mr. Pien served as the Chief Executive Officer and President of Medarex, Inc. from June 14, 2007 to September 2009 and its Chairman of the Board from May 15, 2008 to September 2009. He joined Medarex, Inc. in June 2007. He has over 30 years of pharmaceutical and biotechnology industry experience. Mr. Pien served as the Chief Executive Officer and President of Chiron, Corp. from April ...

Read Full Background

Corporate Headquarters*

2200 Pennsylvania Avenue NW
Washington, District Of Columbia 20037

United States

Phone: 202-734-3400
Fax: 202-296-1450

Board Members Memberships*

1998-2014
Former Lead Independent Director and Chairman of Nominating & Corporate Governance Committee
2003-N/A
Former Chairman, Chief Executive Officer and Member of Stock Option Plan Administration Committee
2007-2009
Former Chairman of the Board, Chief Executive Officer and President
2007-Present
Director, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
2009-Present
Director and Chairman of Compensation Committee
2010-Present
Director, Member of Audit Committee and Member of Compensation Committee
2012-Present
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director and Member of Audit Committee
2014-Present
Director

Education*

MBA 1981
Carnegie Mellon University
BS 1979
Massachusetts Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$44,000
Total Calculated Compensation$104,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $13.32 USD +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.